NCT02941874View on ClinicalTrials.gov

Determining of Normal Values and Conformity Assessment of the Dosage of a Plasmatic Marker of the Cellular Captation of Glucose: the IRAP Protein

CompletedOBSERVATIONAL
Enrollment

96

Participants

Timeline

Start Date

April 7, 2017

Primary Completion Date

September 16, 2019

Study Completion Date

December 12, 2019

Conditions
Insulin Resistance
Interventions
OTHER

Blood sample collection during an OGTT to assess IRAP blood concentration

Blood sample collection during an OGTT to assess IRAP blood concentration. Blood samples will be collected every 15 minutes during 3 hours

Trial Locations (1)

38043

Institut de Biologie - Pathologie, Grenoble

All Listed Sponsors
lead

University Hospital, Grenoble

OTHER

NCT02941874 - Determining of Normal Values and Conformity Assessment of the Dosage of a Plasmatic Marker of the Cellular Captation of Glucose: the IRAP Protein | Biotech Hunter | Biotech Hunter